Ocular Implants Market Size, Share, Forecast, & Trends Analysis by Type (Scleral, Stock, Orbital, Intraocular, Retinal, Corneal) Material (Silicon, Hydroxyapatite) Application (Prosthesis, Ocuplasty, Glaucoma Surgery) End User

Description

List of Tables

Ocular Implants Market Size, Share, Forecast, & Trends Analysis by Type (Scleral, Stock, Orbital, Intraocular, Retinal, Corneal) Material (Silicon, Hydroxyapatite) Application (Prosthesis, Ocuplasty, Glaucoma Surgery) End User-Global Forecast to 2031

The global ocular implants market is projected to reach $23.43 billion by 2031 at a CAGR of 6.1% from 2024 to 2031.

Succeeding extensive secondary and primary research and in-depth analysis of the market scenario, the report comprises the analysis of key industry drivers, restraints, challenges, and opportunities. The growth of the global ocular implants market is driven by the increasing eye problems in the geriatric population, growing adoption of minimally invasive surgeries, rising healthcare expenditure, growing cutting-edge technologies in ocular implants, and an increase in the number of accident cases, raising the need for ocular implants. However, the possibility of post-surgery infection and inflammation, lack of trained ophthalmic surgeons, strict regulations, and approval processes are restraining the growth of this market.

Furthermore, ocular nanotechnology-based drug delivery and ocular tissue engineering are expected to generate market growth opportunities. However, lack of awareness regarding ocular implants in rural areas, technological complexities, high implant costs, and rising product recalls are major challenges in the global ocular implants market.

The report offers a competitive landscape based on an extensive assessment of the product portfolio offerings, geographic presences, and key strategic developments adopted by leading market players in the industry in the past three to four years. The key players operating in the ocular implants market are Alcon Inc. (Switzerland), Bausch + Lomb Corporation (Canada), Carl Zeiss AG (Germany), Johnson & Johnson Vision Care, Inc. (U.S), STAAR SURGICAL COMPANY (U.S), Morcher GmbH (Germany), HOYA CORPORATION (Japan), GLAUKOS CORPORATION (U.S), AbbVie Inc. (U.S.), and Vivani Medical Inc. (U.S).

Among all the types studied in this report, in 2024, the functional implant segment is expected to account for the larger share of 81.7% of the ocular implants market. The functional implant segment is further segmented into intraocular lens, glaucoma implant, retinal implant, and corneal implant. The large share of the segment is attributed to the increasing burden of glaucoma, rising demand for functional implants due to rising eye injuries, and cutting-edge technologies in functional implants. For instance, the Bionic eye is a new technology that improves light sensitivity and generates a sense of vision for vision loss individuals. This technology was developed by the Second Sight company, developed by Mark Humayun, Alfred E. Mann, and Second Sight.

Among all the materials studied in this report, the inert materials segment is expected to account for the largest share of the ocular implant market in 2024. This segment is further categorized into glass, silicone, and methylmethacrylate. The segment's large market share can be attributed to the advantages of inert materials, such as cost-effectiveness, biological compatibility, and no allergic reactions.

Among all the applications studied in this report, in 2024, the glaucoma surgery segment is expected to account for the largest share of 32.6% of the ocular implants market. The large share of the segment is attributed to the increasing burden of glaucoma and the growing demand for functional implants in severe glaucoma cases. Additionally, individuals with diabetes, foresightedness, or eye injury have probably experienced glaucoma. According to the Centers for Disease Control And Prevention, in the U.S., in May 2024, around 38.4 million individuals were living with diabetes, which is 11.6% of the U.S. population.

Among all the end users studied in this report, in 2024, the hospitals segment is expected to account for the largest share of the ocular implants market. The segment's large share is attributed to the increasing number of hospitals specializing in ophthalmology, the availability and accessibility of advanced facilities in hospitals, advanced surgical instruments, and skilled surgical staff. Hospitals are the first preferred health system for accessing medical facilities and treatment, especially for surgical procedures.

An in-depth analysis of the geographical scenario of the global ocular implants market provides detailed qualitative and quantitative insights into the five major geographies (North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa) along with the coverage of major countries in each region. In 2024, North America is expected to account for the largest share of 41.8% of the ocular implants market. The large share of this regional market is attributed to the well-established healthcare infrastructure, high prevalence of eye disorders, presence of key market players, patients' preference for ophthalmic surgeries, and commercial availability of advanced ocular implant products.

Scope of the Report:

Ocular implants Market Assessment-by Type

Non Functional Implants
- Ocular Implants
Scleral shells
Stock Shells
Custom-made Prosthesis
- Orbital Implants
Functional Implants
- Intraocular Lens
- Glaucoma Implants
- Retinal Implants
- Corneal Implants

Ocular Implants Market Assessment-by Material

Inert Materials
- Glass
- Silicone
- Methyl methacrylate
Biointegrated Materials
- Hydroxyapatite
- Porous Polyethylene
- Aluminum Oxide

Ocular Implants Market Assessment-by Application

Ocular Prosthesis
Glaucoma Surgery
Ocuplasty
Drug Delivery
Other Applications

Note: Other applications include vision correction, cosmetic surgery, and age-related macular degeneration.

Ocular Implants Market Assessment-by End User

Hospitals
Ophthalmic Clinics
Ambulatory Surgery Centers (ASCs)
Other End Users

Note: Other end users include academic & research institutes and pharmaceutical & biotechnology companies.

Ocular Implants Market Assessment-by Geography

North America
- U.S.
- Canada
Europe
- Germany
- France
- U.K
- Italy
- Spain
- Switzerland
- Netherlands
- Sweden
- Belgium
- Rest of Europe (RoE)
Asia-Pacific (APAC)
- China
- Japan
- India
- South Korea
- Australia
- Rest of Asia-Pacific (RoAPAC)
Latin America
- Brazil
- Mexico
- Rest of Latin America
Middle East & Africa

Product Code: MRHC - 1041245

1. Introduction

1.1. Market Definition & Scope
1.2. Market Ecosystem
1.3. Currency & Limitations
1.4. Key Stakeholders

2. Research Methodology

2.1. Research Approach
2.2. Data Collection & Validation Process
- 2.2.1. Secondary Research
- 2.2.2. Primary Research/Interviews with Key Opinion Leaders from the Industry
2.3. Market Sizing & Forecasting
- 2.3.1. Market Size Estimation Approach
- 2.3.2. Growth Forecast Approach
- 2.3.3. Market Share Analysis
2.4. Assumptions for the Study

3. Executive Summary

4. Factors Affecting Market Growth

4.1. Overview
4.2. Drivers
- 4.2.1. Rising Geriatric Population Coupled with High Prevalence of Eye Diseases
- 4.2.2. Rise in Adoption of Minimally Invasive Surgeries
- 4.2.3. Increasing Healthcare Expenditure
- 4.2.4. Technological Advancements in Ocular Implants
- 4.2.5. Increasing Accident Cases Raising the Need for Ocular Implants
4.3. Restraints
- 4.3.1. Risk of Post-surgery Infections and Inflammations
- 4.3.2. Lack of Skilled Ophthalmic Surgeons
- 4.3.3. Strict Regulations and Approval Process
4.4. Opportunities
- 4.4.1. Ocular Nanotechnology-based Drug Delivery
- 4.4.2. Ocular Tissue Engineering
4.5. Challenges
- 4.5.1. Lack of Awareness in Rural Areas
- 4.5.2. Technological Complexities
- 4.5.3. High Cost of Implants
- 4.5.4. Increasing Number of Product Recalls
4.6. Trends
- 4.6.1. Biomaterial-based Ocular Implants
- 4.6.2. AI-driven 3D Printed Prosthetic Eyes
- 4.6.3. Drug-eluting Implants
4.7. Factor Analysis
4.8. Regulatory Analysis
4.9. Pricing Analysis
4.10. Case Studies
4.11. Porter's Five Forces Analysis

5. Ocular Implants Market Assessment, by Type

5.1. Overview
5.2. Non Functional Implants
- 5.2.1. Ocular Implant
  - 5.2.1.1. Scleral Shells
  - 5.2.1.2. Stock Shells
  - 5.2.1.3. Custom Made Prosthesis
- 5.2.2. Orbital Implants
5.3. Functional Implants
- 5.3.1. Intraocular Lens
- 5.3.2. Glaucoma Implants
- 5.3.3. Retinal Implants
- 5.3.4. Corneal Implants

6. Ocular Implants Market Assessment, by Material

6.1. Overview
6.2. Inert materials
- 6.2.1. Glass
- 6.2.2. Silicone
- 6.2.3. Methylmethacrylate
6.3. Biointegrated Materials
- 6.3.1. Hydroxyapatite
- 6.3.2. Porous Polyethylene
- 6.3.3. Aluminum Oxide

7. Ocular Implants Market Assessment, by Application

7.1. Overview
7.2. Ocular Prosthesis
7.3. Glaucoma Surgery
7.4. Oculoplasty
7.5. Drug Delivery
7.6. Other Applications

8. Ocular Implants Market Assessment, by End User

8.1. Overview
8.2. Hospitals
8.3. Ophthalmic Clinics
8.4. Ambulatory Surgery Centers (ASCs)
8.5. Other End Users

9. Ocular Implants Market Assessment, by Geography

9.1. Overview
9.2. North America
- 9.2.1. U.S.
- 9.2.2. Canada
9.3. Europe
- 9.3.1. Germany
- 9.3.2. France
- 9.3.3. U.K.
- 9.3.4. Italy
- 9.3.5. Spain
- 9.3.6. Netherlands
- 9.3.7. Switzerland
- 9.3.8. Sweden
- 9.3.9. Belgium
- 9.3.10. Rest of Europe (RoE)
9.4. Asia-Pacific
- 9.4.1. China
- 9.4.2. Japan
- 9.4.3. India
- 9.4.4. Australia
- 9.4.5. South Korea
- 9.4.6. Rest of Asia-Pacific (RoAPAC)
9.5. Latin America
- 9.5.1. Brazil
- 9.5.2. Mexico
- 9.5.3. Rest of Latin America (RoLATAM)
9.6. Middle East & Africa

10. Competition Analysis

10.1. Overview
10.2. Key Growth Strategies
10.3. Competitive Benchmarking
10.4. Competitive Dashboard
- 10.4.1. Industry Leaders
- 10.4.2. Market Differentiators
- 10.4.3. Vanguards
- 10.4.4. Emerging Companies
10.5. Market Share Analysis of Key Players (2023)

11. Company Profiles (Business Overview, Financial Overview, Product Portfolio, and Strategic Developments)

11.1. Alcon Inc.
11.2. Bausch + Lomb Corporation
11.3. Carl Zeiss AG
11.4. Johnson & Johnson Vision Care, Inc.
11.5. STAAR Surgical Company
11.6. Morcher GmbH
11.7. Hoya Corporation
11.8. Glaukos Corporation
11.9. ABBVIE INC.
11.10. Vivani Medical Inc.

(Note: SWOT analyses of the top 5 companies will be provided.

12. Appendix

12.1. Available Customization
12.2. Related Reports